PerkinElmer Names Kaveh Kahen Analytical Solutions President
Kahen, who has more than 20 years of life sciences leadership, will lead the company's Analytical & Testing Solutions business.
Updated on Nov. 4, 2026 in People
PerkinElmer has appointed Dr Kaveh Kahen as president of its Analytical & Testing Solutions business. Kahen previously served as president of Danaher's Abcam and Phenomenex businesses.
Why it matters
The appointment places a leader with prior experience across life sciences and analytical technologies at the head of the ATS unit. The company says the role will focus on accelerating new product development and embedding AI and digital capabilities into laboratory workflows.
Kahen has more than 20 years of global leadership experience and is named as an inventor on 10 US patents. He previously spent eight years at PerkinElmer earlier in his career, and the source does not provide revenue or performance figures for the ATS business.
The players
PerkinElmer
A life sciences and analytical instrumentation company with nearly 90 years of heritage in analytical science, known for its spectroscopy and chromatography products.
Dr Kaveh Kahen
An analytical chemist and executive who holds a Ph.D. in Analytical Chemistry from The George Washington University and previously led Danaher's Abcam and Phenomenex businesses.
The details
Kahen previously led Abcam, where he oversaw deployment of a unified digital platform across global sites, and Phenomenex, where he guided renewed growth. He also served as chief executive officer of Advion Interchim Scientific and co-founded Sigma Analytical Services. PerkinElmer's LabPilot platform, which connects instruments, software and services in one environment, is part of the company's current offering.
Timeline
November 4, 2026: PerkinElmer announces Kahen's appointment as ATS president.
Market Landscape
The move reflects a broader push among analytical instrument makers to connect hardware, software and services into integrated digital platforms such as PerkinElmer's LabPilot. Leadership changes like this one signal how companies are positioning themselves in a competitive field focused on AI-enabled laboratory workflows.
Laboratories that rely on PerkinElmer's analytical instruments may see new product development and AI-enabled workflow tools under Kahen's leadership. The source does not specify any changes to pricing or product availability.
The takeaway
Leadership changes at analytical instrument makers often signal shifts in product strategy, so watch for new product launches and digital platform updates from PerkinElmer in the coming months. Professionals who depend on these tools can track how connected platforms like LabPilot evolve.
Further reading
Explore more People coverage in the business section for context on executive moves in the industry.
Source note: This article includes information reported by Pharmabiz.
